BIOMAT Database Logo BIOMAT Database Logo

Immunosuppressant and infliximab-resistant generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis. 2012

Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D001781 Blood Component Removal Any procedure in which blood is withdrawn from a donor, a portion is separated and retained, at the same time the remainder is returned to the donor. Apheresis,Pheresis,Aphereses,Blood Component Removals,Phereses,Removal, Blood Component
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069285 Infliximab A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. Inflectra,Infliximab-abda,Infliximab-dyyb,MAb cA2,Monoclonal Antibody cA2,Remicade,Renflexis,Antibody cA2, Monoclonal,Infliximab abda,Infliximab dyyb,cA2, Monoclonal Antibody
D000327 Adsorption The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily. Adsorptions

Related Publications

Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis.
August 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis.
December 2011, The Journal of dermatology,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Generalized Pustular Psoriasis With CARD14 Variant c.526G>C (p.Asp176His) Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis.
June 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Intensive granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis.
November 2020, The Journal of dermatology,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist successfully treated with granulocyte and monocyte adsorption apheresis.
December 2014, Journal of the European Academy of Dermatology and Venereology : JEADV,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Genetic background and therapeutic response in generalized pustular psoriasis patients treated with granulocyte and monocyte adsorption apheresis.
February 2018, European journal of dermatology : EJD,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis.
August 2003, Journal of the American Academy of Dermatology,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Successful treatment of three cases of generalized pustular psoriasis with granulocyte and monocyte adsorption apheresis.
October 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Infliximab- and immunosuppressant-resistant Crohn's disease successfully treated with adsorptive granulocyte apheresis combined with prednisolone.
January 2012, Case reports in gastroenterology,
Kyoko Furusawa, and Toshio Hasegawa, and Shigaku Ikeda
Mild generalised pustular psoriasis patient with a heterozygous hypomorphic MPO variant successfully treated with granulocyte and monocyte adsorption apheresis.
September 2023, Experimental dermatology,
Copied contents to your clipboard!